Department of Radiation Oncology, Instituut Verbeeten, Tilburg, the Netherlands.
Medifit Fysiotherapie Instituut Verbeeten, Tilburg, the Netherlands.
BMC Cancer. 2024 Apr 1;24(1):403. doi: 10.1186/s12885-024-12172-2.
During the last decade, twelve studies have been published investigating physical exercise interventions (PEIs) in patients with head and neck cancer (HNC) during radiotherapy (RT), chemoradiation (CRT) or bioradiation (BRT). These studies showed that these PEIs are safe and feasible. However, only two of these studies were randomised clinical trials (RCTs) with a satisfying sample size. Thereby, there is no cost-effectiveness study related to a PEI during RT, CRT or BRT ((C/B)RT) for patients with HNC. Therefore, the aim of this study is to investigate and compare physical performance, muscle strength, fatigue, quality of life (QoL), body mass index (BMI), nutritional status, physical activity, treatment tolerability, and health care related costs in patients with HNC with and without a 10 week PEI during (C/B)RT.
This study, based on a trial within cohorts (TwiCs) design, will contain a prospective cohort of at least 112 patients. Fifty-six patients will randomly be invited for an experimental 10 week PEI. This PEI consists of both resistance and endurance exercises to optimize physical performance, muscle strength, fatigue, QoL, BMI, nutritional status, physical activity, and treatment tolerability of (C/B)RT. Measurements are at baseline, after 12 weeks, 6 months, and at 12 months. Statistical analyses will be performed for intention-to-treat and instrumental variable analysis.
This study seeks to investigate physical, QoL, and economic implications of a PEI. With a substantial sample size, this study attempts to strengthen and expand knowledge in HNC care upon PEI during (C/B)RT. In conclusion, this study is dedicated to provide additional evidence for PEI in patients with HNC during (C/B)RT.
protocol was registered at clinicaltrials.gov with number NCT05988060 on 3 August 2023.
在过去的十年中,已经发表了 12 项研究,调查了头颈部癌症(HNC)患者在放疗(RT)、放化疗(CRT)或放生物治疗(BRT)期间进行身体运动干预(PEI)的情况。这些研究表明这些 PEI 是安全且可行的。然而,其中只有两项研究是具有令人满意样本量的随机临床试验(RCT)。因此,目前还没有关于 HNC 患者在 RT、CRT 或 BRT 期间进行 PEI 的成本效益研究。因此,本研究的目的是调查和比较在(C/B)RT 期间接受和不接受为期 10 周的 PEI 的 HNC 患者的身体机能、肌肉力量、疲劳、生活质量(QoL)、体重指数(BMI)、营养状况、身体活动、治疗耐受性以及与健康相关的成本。
本研究基于试验内队列(TwiCs)设计,将包含至少 112 名患者的前瞻性队列。将随机邀请 56 名患者参加为期 10 周的实验性 PEI。该 PEI 包括阻力和耐力运动,以优化(C/B)RT 的身体机能、肌肉力量、疲劳、QoL、BMI、营养状况、身体活动和治疗耐受性。测量在基线时、第 12 周、6 个月和 12 个月时进行。将进行意向治疗和工具变量分析的统计分析。
本研究旨在调查 PEI 的身体、QoL 和经济影响。通过较大的样本量,本研究试图在 HNC 治疗中加强和扩展对 PEI 的认识。总之,本研究旨在为 HNC 患者在(C/B)RT 期间进行 PEI 提供额外的证据。
方案于 2023 年 8 月 3 日在 clinicaltrials.gov 上注册,编号为 NCT05988060。